Part of the Pharmaceutics and Drug Design Commons
Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton Alison M. Walton
PDF
Use of a Subcutaneous Insulin Computerized GlucoStabilizer™ Program on Glycemic Control in the Intensive Care Setting: A Retrospective Data Analysis., Sarah A. Nisly, Serena Harris, Laura Aykroyd, Joni Carrol, Brian Ulmer, Michael Waddell, Samuel Flanders, Rattan Juneja Sarah A. Nisly
Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton Sarah A. Nisly
Canagliflozin, a New Sodium-Glucose Co-Transporter 2 Inhibitor, in the Treatment of Diabetes, Sarah A. Nisly, Denise M. Kolanczyk, Alison M. Walton Scholarship and Professional Work – COPHS
Use of a Subcutaneous Insulin Computerized GlucoStabilizer™ Program on Glycemic Control in the Intensive Care Setting: A Retrospective Data Analysis., Sarah A. Nisly, Serena Harris, Laura Aykroyd, Joni Carrol, Brian Ulmer, Michael Waddell, Samuel Flanders, Rattan Juneja Scholarship and Professional Work – COPHS
Advanced Search
Search Help